Medical/Pharmaceuticals
COVID-19: Doctor's certificates for antigen self-tests now offered online worldwide by DrAnsay.com
HAMBURG, Germany, July 8, 2021 /PRNewswire/ -- DrAnsay.com, the market leader
for online doctor attests, now offers online test certificates for self-applied
rapid antigen tests worldwide to avoid the effort, infection risk and cost of
point-of-care testing.
2021-07-08 13:55
3450
BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer
SHANGHAI, July 8, 2021 /PRNewswire/ -- BioShin Limited today announced the appointment of Dr.Zhihong (Sarah) Lu as Chief Medical Officer and Dr. Ma (Mary) Li as Chief Commercial Officer. Sarah will play a critical role in BioShin's clinical development of pipeline products inAsia-Pacific markets,...
2021-07-08 12:01
2526
Just 5 minutes: Game-changing PCR to complete nucleic acid amplification, Si-Gene Biotech help out against COVID 19
SHANGHAI, July 8, 2021 /PRNewswire/ -- As is known, nucleic acid detection is currently the "golden standard" of coronavirus detection and has the high sensitivity and specificity characteristics in early diagnosis. The most common method for detecting novel coronavirus-specific nucleic acid sequ...
2021-07-08 11:28
2342
BeatO raises USD 5.7 million in funding led by W Health Ventures
- Fresh funds to be utilized in enlarging its subscriber base across channels/geographies and for product enhancement to provide care for more cardiometabolic conditions NEW DELHI, July 8, 2021 /PRNewswire/ -- BeatO – India's leading digital care ecosystem for chronic condition management – has ...
2021-07-08 08:30
3522
CStone announces updated results for AYVAKIT(R) (avapritinib) in Chinese patients with advanced GIST at ESMO World Congress on Gastrointestinal Cancer 2021
* AYVAKIT has demonstrated significant anti-tumor activity in Chinese patients with PDGFRA D842V mutant gastrointestinal stromal tumor (GIST), and has also shown potential for the treatment of fourth-line GIST * AYVAKIT had a generally well-tolerated safety profile in Chinese patients with GI...
2021-07-08 08:05
4845
Cambridge Isotope Labs Announces the First Commercially Available Quantum-Grade Gas, 12C Methane QG-Alpha™ for High-Performance Nitrogen-Vacancy Center Diamonds
TEWKSBURY, Mass., July 8, 2021 /PRNewswire/ -- Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, is proud to launch the first commercially available 12C-enriched methane-grade gas for quan...
2021-07-08 03:24
1688
Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
PRINCETON, N.J., July 8, 2021 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. ("Otsuka"), announces today that it has entered a three-year collaboration with Holmusk Inc. ("Holmusk"), a global data science and digital health company building the world's largest real-wo...
2021-07-08 00:56
3321
Ortho Clinical Diagnostics Announces Partnership With Thermo Fisher Scientific
Introducing VITROS® QC Solutions, taking your lab to the next level with Thermo Scientific™ MAS™ Quality Controls RARITAN, N.J., July 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its...
2021-07-07 21:00
31281
dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors
SHANGHAI and MORRISVILLE, N.C., July 7, 2021 /PRNewswire/ -- dMed-Clinipace, the global full-service Clinical Contract Research Organization (CRO), announced today the recent successful completion of aUS$50 million Series C+ financing with participation from a group of new, leading international ...
2021-07-07 20:00
4261
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
BOSTON and BEIJING, July 7, 2021 /PRNewswire/ -- Eucure Biopharma, a wholly
owned subsidiary of Biocytogen
2021-07-07 16:41
2840
Elekta optimizes treatment times for cancer patients via proactive service innovation
STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these solutions ...
2021-07-07 14:38
32722
Innophys' MUSCLE SUIT Selling Steadily after Topping 20,000 Units
TOKYO, July 7, 2021 /PRNewswire/ -- Developed and sold by Innophys Co., Ltd., MUSCLE SUIT has been selling steadily even after exceeding 20,000 units in cumulative total (*1) all over the world recently, making it a fast-selling (*2) exoskeleton assist suit in the world. Notes: (*1) Total numbe...
2021-07-07 14:00
3397
CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy
SUZHOU, China, July 7, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational new ...
2021-07-07 08:05
3557
New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®
* STELFONTA® (tigilanol tiglate) is now approved by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the treatment of canine non-metastatic mast cell tumours (MCT). * APVMA approval follows marketing authorisation (registration) and launch of STELFONTA® in the major co...
2021-07-07 06:34
2155
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax
PROVIDENCE, R.I., July 7, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Dr. Rosenber...
2021-07-07 01:43
2702
Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody TST002
SUZHOU, China, July 6, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announces that NMPA has accepted IND applica...
2021-07-06 21:36
1985
Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis
* Both batoclimab 340 mg and 680 mg treatment groups demonstrated rapid, substantial and persistent clinical improvement over placebo * Favorable safety and tolerability profile with no serious adverse events (SAEs) and no adverse events (AEs) leading to discontinuation * Strong IgG reductio...
2021-07-06 21:06
18406
Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility
XIAN, China, July 6, 2021 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health and personal care industries, today announced that they have received the certificate of a land use right for the future si...
2021-07-06 21:00
4470
RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally
TORONTO, July 6, 2021 /PRNewswire/ -- RamSoft, a leading healthcare IT software and services company, today announced it has taken a majority stake in Meddiff Technologies, an innovative medical imaging solutions company. This acquisition will accelerate RamSoft's product development by combining...
2021-07-06 21:00
1885
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD
ADELAIDE, Australia, July 6, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a global, clinical stage biopharmaceutical company, is pleased to announce that it has initiated a Phase2b trial (the ATTUNE Study) to evaluate the tablet formulation of BNC210 in p...
2021-07-06 18:00
17512
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
5428
